Pricing Log in Create free account

Seres Therapeutics, Inc. (MCRB) vs Polyrizon Ltd. (PLRZ)

Seres Therapeutics, Inc. and Polyrizon Ltd. are both Biotechnology companies. Seres Therapeutics, Inc. and Polyrizon Ltd. are of similar size ($25.2M and $23.7M). Across the 8 metrics below, Polyrizon Ltd. leads on 7 and Seres Therapeutics, Inc. on 1.

Valuation

Metric MCRB PLRZ Biotechnology median
P/E n/m — 8.50
P/S 12.68 — 9.71
P/B 0.69 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 58.83 n/m 9.21
Earnings yield (98.78%) — (33.15%)
Free cash flow yield (214.65%) 0.00% (25.50%)

Profitability

Metric MCRB PLRZ Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (4,462.77%) — 0.00%
Net margin (1,192.94%) — 0.00%
Free cash flow margin (2,721.83%) 0.00% 0.00%
Return on equity (66.57%) 0.00% (56.36%)
Return on assets (18.31%) 0.00% (48.04%)
Return on invested capital (277.30%) 0.00% 0.00%

Growth

Metric MCRB PLRZ Biotechnology median
Revenue growth (TTM) (98.51%) — 6.02%
EPS growth (last fiscal year) 0.00% 99.37% 30.26%
Revenue growth, 5-year CAGR (53.03%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MCRB PLRZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.11 36.37 4.72
Net debt to EBITDA 0.51 2.11 0.96

Dividend

Metric MCRB PLRZ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MCRB PLRZ Biotechnology median
Market cap 25.15m 23.74m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack